Portal de Periódicos da CAPES

Subgroup analysis of phase 3 study of fixed-dose combination of dapagliflozin, glimepiride and metformin IR in type 2 diabetes mellitus patients with HbA1c 9%-11%

2024; Bioscientifica; Linguagem: Inglês

10.1530/endoabs.99.p471

2046-0368

Prakash Kurmi, Manish Singh, Vishal Gupta, Chikkalingaiah Siddegowda, Jitendra Kumar Shukla, Sandip Gofne, Nilesh Lomte, Kaustubh Shendkar, Dinesh Gangwani, Surendra Kumar, Sandeep K. Gupta, Nagarajaiah Aravind G, Amit Bhaskar, Prabhat Sharma, Arjun Baidya, Animesh Maiti, Ambana Gowda, Jayesh Ambaliya, K Balachandra Giriappa, Sunil Mahavar, Hemant Gupta, Rajurkar Dr Mandodari, Supriya Sonowal, Piyush M. Patel, Dipak D. Patil, Lalit Lakhwani, Pravin Ghadge, Suyog Mehta, Sadhna Joglekar,

Natural Antidiabetic Agents Studies

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)